Skip to content

Transperineal or transrectal prostate biopsy

The two routes side by side, what randomized trials show and what each guideline recommends.

Dr. Petronio Melo, urologistA reference in prostate cancer
CRM-SP 157.598 · RQE 70.275
Reviewed by Dr. Petronio Melo on November 16, 2026
Book a consultation
Drawing of two side views of the pelvis: on the left, the needle enters through the perineum; on the right, it comes out of the ultrasound probe and crosses the rectal wall
On this page

Quick answer

In the transperineal route, the needle goes in through the skin of the perineum, between the scrotum and the anus. In the transrectal route, it crosses the wall of the rectum, which is why the risk of infection is higher.1 The European guideline recommends the transperineal route, and the American guideline accepts both.1,2 For cancer detection, randomized trials show similar or slightly better results with the transperineal route.4,10 I prefer the transperineal route, but the choice is discussed with each patient.

How each route works

In both routes, the ultrasound probe sits in the rectum and shows the prostate on the screen. What changes is the path of the needle. In the transperineal route, it goes through the skin of the perineum, which is disinfected first, as in surgery. In the transrectal route, it passes through the wall of the rectum, which carries bacteria from the bowel. That is why the European guideline calls for cleaning the rectum with povidone-iodine and for antibiotics before a transrectal biopsy.1

In both, sampling can be guided by the MRI images, either with software on the ultrasound machine or with cognitive fusion. I explain both in MRI fusion biopsy. The whole procedure, from start to finish, is on the transperineal biopsy page.

The two side by side

ItemTransperinealTransrectal
Where the needle goes1Skin of the perineumWall of the rectum
Infection in 8 randomized trials122 in 807 men48 in 789 men
Sepsis, in one review10.1%0.9%
Antibiotics1Can be skipped in men without risk factorsNeeded, ideally chosen from a rectal culture
Significant cancer, with MRI10SimilarSimilar
Lesions in the front7Higher detectionLower detection
Rectal bleeding8Rare: 95% lower riskMore common
Retention needing a catheter, in TRANSLATE46%5%
Pain during the procedure10Slightly moreSlightly less
Brazilian health plans, in my experienceNot covered yetCovered

Infection and antibiotics

Infection is the main difference between the two routes. In eight randomized trials pooled by the European guideline, it was more common after a transrectal biopsy. Sepsis, an infection that spreads through the blood, was 0.1% with the transperineal route and 0.9% with the transrectal route in one review.1 A review of 12 randomized trials, with 4,244 men, also found fewer infections with the transperineal route, and even fewer severe infections.10

The gap shrinks when the transrectal biopsy is done carefully. In PREVENT, men in the transrectal group received antibiotics chosen from a rectal culture, and the difference was not statistically significant.3 In ProBE-PC, infection was 2.7% with the transperineal route and 2.6% with the transrectal route, and no one had sepsis.5 In that trial, all men in the transrectal group received antibiotics, but only 4 of the 367 in the transperineal group, those at higher risk.2

Antibiotics are the other difference. With the transperineal route, the European guideline accepts skipping them in men without risk factors, such as diabetes or a history of urinary retention.1 In a randomized trial in Norway and Germany, with 555 men, no one had sepsis or a hospital stay for infection, with or without antibiotics.9 With the transrectal route, the guideline calls for antibiotics guided by a rectal culture or, without one, a combination of two antibiotics.1 Using fewer antibiotics also helps slow bacterial resistance, a concern raised by the American guideline.2

Cancer detection

When the biopsy is guided by MRI, both routes find significant cancer at similar rates. Without MRI, the transperineal route did slightly better.10 TRANSLATE, with 1,126 men, was the only randomized trial to show higher detection with the transperineal route.4 The American guideline notes that almost all of the difference came from grade group 2 tumors, with no difference for grade group 3 or higher.2 What the grade means is explained in Gleason and ISUP.

Where the lesion sits matters. The front of the prostate is far from the rectum and harder to reach through the transrectal route.2 In a review of 11 studies, most of them retrospective, the transperineal route found more significant cancer in lesions at the front and at the apex, the tip of the prostate.7 In the randomized PERFECT trial, front lesions were detected more often with the transperineal route (40.6% versus 26.5%), without statistical significance, and back lesions more often with the transrectal route (59.0% versus 44.3%).6

Bleeding, retention and pain

Rectal bleeding is much less common with the transperineal route. In a review of 20 studies, the risk was 95% lower, and fever was also less common.8 The American guideline adds that long-lasting blood in the semen is more common after a transrectal biopsy.2 Blood in the urine was similar with both routes.8

Urinary retention, when urine cannot come out and a catheter is needed, was similar in randomized trials. In TRANSLATE, it happened in 6% with the transperineal route and in 5% with the transrectal route.4,10

Pain during the procedure was slightly higher with the transperineal route in randomized trials.10 In PREVENT, with the biopsy done in the office, the difference was 0.6 points on a 0 to 10 scale and was gone by 7 days.3 In my practice, the biopsy is always done with sedation. What can happen afterward is covered in prostate biopsy complications.

What the guidelines recommend

The 2026 European guideline strongly recommends doing the biopsy through the transperineal route, because of the low risk of infection. It also recommends skipping antibiotics for a transperineal biopsy in men without risk factors, as a weak recommendation. For a transrectal biopsy, it calls for cleaning the rectum with povidone-iodine and for antibiotics guided by a rectal culture.1

The American guideline (AUA and SUO), updated in 2026, says doctors may use either route, as a conditional recommendation. In the panel's view, trials have not yet shown that the transperineal route finds more significant cancer or reduces infection enough to make it the only option. The same guideline sees special value in the transperineal route for men who had an infection after a previous biopsy, are at higher risk of infection or have a lesion in the front of the prostate.2

Why the transrectal route is still used

The transrectal route is the traditional one.3,4 It remains a safe option, as ProBE-PC concluded.5 The American guideline notes that it may be the right choice in some situations, such as patient preference, a man who cannot be placed in the position needed for the procedure or a lack of equipment for the transperineal route. Antibiotics guided by a rectal culture and other measures reduce sepsis.2

In my experience, Brazilian health plans still cover only the transrectal route, and this weighs on many patients' decisions. I explain what goes into the cost in prostate biopsy cost and insurance.

How I approach it

I have performed transperineal prostate biopsy since 2022, and it is the route I prefer. Before recommending a biopsy, I ask for an MRI. With PI-RADS 3 or higher, in my practice, a biopsy is always recommended. It is done in the operating room, always with sedation, takes about 20 minutes and, with the transperineal route, does not require antibiotics. I use cognitive fusion and take samples from the lesion seen on MRI and from the rest of the prostate. You go home the same day, with a companion.

The transrectal route remains an option. At the consultation, I explain the differences, we look at the MRI, the risk of infection and your coverage, and the decision is made together with you. I hold a PhD from the University of São Paulo Medical School, with award-winning research on artificial intelligence in prostate cancer diagnosis, and I co-authored a randomized trial comparing biopsy with 12 and with 20 cores, presented at the AUA annual meeting in 2017. The first consultation can be online, in English.

When to see a urologist

  • If you have been asked to have a biopsy and want to understand which route makes more sense for you
  • If your MRI showed a PI-RADS 3, 4 or 5 lesion, especially in the front of the prostate
  • If you had an infection after a previous biopsy
  • If you have diabetes or another risk factor for infection
  • If you had fever, difficulty urinating or blood with clots after a biopsy: get in touch the same day

Frequently asked questions

Which is better, transperineal or transrectal?

It depends on the case. The European guideline recommends the transperineal route because of the lower risk of infection.1 The American guideline accepts both routes.2 In randomized trials, cancer detection was similar or slightly higher with the transperineal route.4,10 In my practice, I prefer the transperineal route, and the choice is made together with you.

Does a transperineal biopsy find more cancer?

When the biopsy is guided by MRI, results are similar.10 In TRANSLATE, the largest randomized trial, the transperineal route found significant cancer in 60% of men and the transrectal route in 54%.4 For lesions in the front of the prostate, a review of mostly retrospective studies showed higher detection with the transperineal route.7

Does a transrectal biopsy cause more infections?

In eight randomized trials pooled by the European guideline, there were 48 infections in 789 men with the transrectal route and 22 in 807 with the transperineal route.1 With antibiotics chosen from a rectal culture, the gap gets small. In PREVENT, it was 0 versus 1.4%, without statistical significance.3

Do I need antibiotics for the biopsy?

With the transperineal route, the European guideline accepts skipping antibiotics in men without risk factors, such as diabetes or a history of urinary retention. With the transrectal route, they are needed.1 In my practice, the transperineal biopsy is done without antibiotics, even in men with diabetes or a history of urinary retention.

Why do Brazilian health plans cover only the transrectal biopsy?

In my experience, Brazilian health plans still cover only the transrectal route. The details are in [prostate biopsy cost and insurance](/en/prostate-cancer/biopsy-cost-and-insurance/).

Which one hurts more?

In the trials, the transperineal route was slightly more painful during the biopsy.3,10 In PREVENT, done in the office, the difference was small and gone by 7 days.3 In my practice, the biopsy is always done with sedation. Afterward, there may be mild pain in the perineum for the first few days.

Who performs transperineal prostate biopsy in São Paulo?

I have performed transperineal prostate biopsy in São Paulo since 2022. I am Dr. Petronio Melo, a urologist and robotic surgeon, CRM-SP 157.598 and RQE 70.275. I hold a PhD from the University of São Paulo Medical School, with award-winning research on artificial intelligence in prostate cancer diagnosis, and I have performed more than 1,500 robotic and laparoscopic surgeries, more than 500 of them robotic. In my practice, the biopsy is always done with sedation. My office is in Vila Mariana, and the first consultation can be in person or online, in English.

References

  1. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. European Association of Urology; 2026. EAU
  2. Wei JT, Barocas D, Carlsson S, et al. Early Detection of Prostate Cancer: AUA/SUO Guideline (2023, amended 2026). American Urological Association; 2026. Update: Lin DW, Carlsson S, Filson CP, et al. J Urol. 2026;215(5):491-501. AUA
  3. Hu JC, Assel M, Allaf ME, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. 2024;86(1):61-68. PubMed
  4. Bryant RJ, Marian IR, Williams R, et al. Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial. Lancet Oncol. 2025;26(5):583-595. PubMed
  5. Mian BM, Feustel PJ, Aziz A, et al. Complications Following Transrectal and Transperineal Prostate Biopsy: Results of the ProBE-PC Randomized Clinical Trial. J Urol. 2024;211(2):205-213. PubMed
  6. Ploussard G, Barret E, Fiard G, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1). Eur Urol Oncol. 2024;7(5):1080-1087. PubMed
  7. Uleri A, Baboudjian M, Tedde A, et al. Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy in Clinically Significant Prostate Cancer Detection Rate? A Systematic Review and Meta-analysis. Eur Urol Oncol. 2023;6(6):621-628. PubMed
  8. Du J, Chen S, Terris MK, et al. Comparison of prostate cancer detection rates and complications between transrectal ultrasound-guided transperineal and transrectal biopsies: a systematic review and meta-analysis. Transl Androl Urol. 2025;14(5):1418-1428. PubMed
  9. Jacewicz M, Günzel K, Rud E, et al. Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial. Lancet Infect Dis. 2022;22(10):1465-1471. PubMed
  10. Yang YJ, Yang EJ, Nguyen TT, et al. Transperineal Versus Transrectal Prostate Biopsy: A Systematic Review and Meta-analysis of Randomized Controlled Trials Across Settings With and Without Magnetic Resonance Imaging Targeting. Eur Urol Open Sci. 2026;83:205-218. PubMed

Would you like to talk about your case?

In the consultation, I go over your tests and your priorities.

Book a consultation

Related guides